Insulet (NASDAQ:PODD – Free Report) had its target price hoisted by JPMorgan Chase & Co. from $280.00 to $330.00 in a research report sent to investors on Thursday morning,Benzinga reports. They ...
The company's lineup also includes other blockbuster drugs with strong momentum. Sales of autoimmune disease drug Taltz, breast cancer drug Verzenio, and fast-acting insulin Humalog soared by 17% or ...
But his new passport angered critics of Italy’s rules on citizenship. By arming civilians who are poorly trained and have little to no respect for human rights, the military in Burkina Faso has ...
After a prominent turn on ‘The Daily Show’ and a buzzy podcast, the comedian says she got a lot of offers just to play herself. But that’s not the career the Emmy-nominated ‘Shrinking’ star envisioned ...